Napier Financial’s Edwards Lifesciences EW Stock Holding History

Napier Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.2K	Sell	721 -2	-0.3%	-$168	0.01%	196
2026 Q1	$57.9K	Buy	+723	New	+$59.6K	0.01%	199

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Napier Financial's EW Position: Q2 2026 in Review

Napier Financial reduced its Edwards Lifesciences (EW) stake by 0.28% in Q2 2026, selling an estimated $168 and leaving 721 shares worth $65.2K. The position accounts for 0.01% of the portfolio, ranked #196.

Napier Financial first reported a position in EW in Q1 2026 and has held it in 2 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Napier Financial held 721 shares of Edwards Lifesciences worth $65.2K as of Q2 2026.
Napier Financial sold 2 Edwards Lifesciences shares in Q2 2026, an estimated $168.
Edwards Lifesciences made up 0.01% of Napier Financial's portfolio in Q2 2026, its #196 holding.
Napier Financial first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Napier Financial's 13F filing for Q2 2026, filed 31 Jul 2026.